We are passionate about teaching cardiovascular imaging to the medical community!
Joined September 2019
- Tweets1.2K
- Following329
- Followers667
- Likes740
Groundbreaking work that Elazer Edelman is doing in endothelium and biomaterials using imaging as endpoint
If you want to know more about CV imaging, follow us and read our articles! @IntJCVImaging
#echofirst
#yescct
#whyCMR
This Post is from a suspended account. Learn more
What a great moment to be working in HFpEF specifically and cardiometabolism in general!
Wanna learn how to evaluate HFpEF using imaging? Read our journal @IntJCVImaging
#echofirst #yesCCT
#whyCMR
This Post is from a suspended account. Learn more
Non-invasive methods to replace cardiac biopsy in heart transplant surveillance. Way to go, @JeffTeuteberg @Stanford_HF!👏
If you focus on non-invasive evaluation of the heart, read @IntJCVImaging!
@purviparwani @CASivaram1 @argulian @LucySafi
@DrRyanPDaly @onco_cardiology
This Post is from a suspended account. Learn more
Cardiometabolism evaluation via imaging techniques = @PamTaubMD
Cardiometabolism improvement via time-restricted eating=@PamTaubMD
This Post is from a suspended account. Learn more
Do not miss this session!
@SantosGallegoMD uses imaging to evaluate the effect of therapies, both for HFrEF and for HFpEF
If you want to learn more about imaging, ready our journal @IntJCVImaging
#cardioed #meded #echofirst #yesCCT #whyCMR
This Post is from a suspended account. Learn more
That is a hefty cut!!
Efficacy of SGLT2i on HF demonstrated both clinically and using imaging.
For imaging studies in HF, please read @IntJCVImaging #echofirst #whyCMR #yesCCT #cardioed #meded
This Post is from a suspended account. Learn more
RV evaluation is very tricky. If you want to it properly
1) learn from the master himself @RyanTedfordMD
2) read our journal @IntJCVImaging
#echofirst #whyCMR #yesCCT
#cardioed @NephroP
This Post is from a suspended account. Learn more
International Journal of Cardiovascular Imaging retweeted
Identification of acute aortic syndromes based on cross-sectional vari... sciencedirect.com/science/ar…
Great use of cardiovascular imaging techniques to demonstrate that empagliflozin reduces MI size!
If you want to learn more about cardiac imaging, read our journal @IntJCVImaging
Should we consider increased ketone body levels as one of the mechanisms of action involved in the cardiorenal benefit of SGLT2i?
Our recent article supports this concept! @santosgallegoMD @RequenaIbanez
@dlbhattmd @IcahnMountSinai @SinaiCards
ahajournals.org/doi/abs/10.1…
Great editorial comment about the CLEAR Outcomes trial by the world-renown lipid expert @juanbadimon
As we are an imaging journal, this trial could only be better if it also had imaging endpoints!
#whyCMR #yesCCT #echofirst
Everything you wanted to know about the CLEAR-Outcomes trial, but were afraid to ask.
Read my view on the latest @secardiologia blog entry
LDL, the lower the better, the earlier the better!
secardiologia.es/blog/14179-…
@lipidmir @ResiSec #cardioed #meded @Capijorge1
Great review by @SantosGallegoMD about techniques to quantify congestion, including VExUS!
#cardioed #meded #echofirst #yesCCT #whyCMR
"EMPULSE: en insuficiencia cardiaca aguda, empagliflozina causa mejoría de la congestión temprana, efectiva y sostenida en el tiempo, que se asocia con beneficio clínico a largo plazo", señala @santosgallegoMD. #BlogSEC @jovenesSEC ow.ly/yP4j50MV3xk
That is why we chose @SantosGallegoMD as Associate Editor of our journal @IntJCVImaging
With every passing day I learn that @SantosGallegoMD is an expert on another topic (SGLT2i, Spanish wine, opera, Futbol, tapas, bourbon…the list is endless). @rachkataria and @JonathanDavisHF decided that he is the most interesting man in the world. (#AHA22 edition)